Research Article

Involvement of Fibroblast Growth Factor Receptor Genes in Benign Prostate Hyperplasia in a Korean Population

Table 2

Frequencies of the genotypes and alleles of polymorphisms of FGFR genes in BPH patients and control subjects.

GeneSNPGenotype/alleleControlBPHModelsOR (95% CI)
(%) (%)

FGFR1 rs13317T/T85 (39.9)83 (35.6)Additive1.11 (0.83–1.47)0.48
T/C100 (47.0)116 (49.8)Dominant1.16 (0.79–1.72)0.45
C/C28 (13.2)34 (14.6)Recessive1.09 (0.63–1.90)0.75
T270 (63.4)282 (60.5)1
C156 (36.6)184 (39.5)1.13 (0.86–1.48)0.38

FGFR2 rs755793T/T193 (90.6)208 (89.3)Additive1.08 (0.59–2.00)0.80
T/C20 (9.4)24 (10.3)Dominant1.04 (0.55–1.96)0.90
C/C0 (0.0)1 (0.4)RecessiveNA (0.00-NA)NA
T406 (95.3)440 (94.4)1
C20 (4.7)26 (5.6)1.20 (0.66–2.18)0.55
rs1047100 G/G193 (90.6)196 (84.1)Additive1.92 (1.07–3.43)0.024
G/A20 (9.4)35 (15.0)Dominant1.89 (1.04–3.45)0.034
A/A0 (0.0)2 (0.9)RecessiveNA (0.00-NA)NA
G406 (95.3)427 (91.6)1
A20 (4.7)39 (8.4)1.85 (1.06–3.23)0.029
rs3135831C/C92 (43.2)116 (49.8)Additive0.83 (0.63–1.09)0.17
C/T88 (41.3)90 (38.6)Dominant0.80 (0.55–1.18)0.26
T/T33 (15.5)27 (11.6)Recessive0.72 (0.41–1.25)0.24
C272 (63.8)322 (69.1)1
T154 (36.2)144 (30.9)0.79 (0.60–1.04)0.10